{"created":"2023-06-19T10:43:35.527163+00:00","id":3835,"links":{},"metadata":{"_buckets":{"deposit":"c00d9fbb-9819-4c48-83ba-cc595504588c"},"_deposit":{"created_by":11,"id":"3835","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"3835"},"status":"published"},"_oai":{"id":"oai:shiga-med.repo.nii.ac.jp:00003835","sets":["30:66:216","77:280:281"]},"author_link":["8455","8454","564","8351","8458","8456","8457"],"item_4_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-03","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"233","bibliographicPageStart":"226","bibliographicVolumeNumber":"64","bibliographic_titles":[{},{"bibliographic_title":"Obstetrics and Gynecology Science","bibliographic_titleLang":"en"}]}]},"item_4_creator_3":{"attribute_name":"著者別名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"米岡, 完"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"村上, 節"}],"nameIdentifiers":[{},{},{}]}]},"item_4_description_14":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"pdf","subitem_description_type":"Other"}]},"item_4_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Objective:\nThis study aimed to investigate the prognosis of patients with intermediate-risk cervical cancer and to evaluate the necessity of adjuvant therapy. ","subitem_description_type":"Abstract"},{"subitem_description":"Methods:\nWe conducted a retrospective chart review of patients with stage IB-II cervical cancer who underwent type III radical hysterectomy with pelvic lymphadenectomy between 2008 and 2017. In our institution, radical hysterectomy is performed as an open surgery and not as a minimally invasive surgery, and adjuvant therapy is not administered to patients with intermediate-risk cervical cancer. The intermediate-risk group included patients with 2 or more of the following factors: tumor size >4 cm, stromal invasion >1/2, and lymphovascular stromal invasion. Intermediaterisk patients with squamous cell carcinoma were included in the I-SCC group, whereas those with endocervical adenocarcinoma, usual type, or adenosquamous carcinoma were included in the I-Adeno group. ","subitem_description_type":"Abstract"},{"subitem_description":"Results:\nThere were 34 and 18 patients in the I-SCC and I-Adeno groups, respectively. The 5-year recurrence-free survival (RFS) and overall survival rates in the I-SCC group were 90.5% (95% confidence interval [CI], 85.3-95.7%) and 100% (95% CI, 100%), respectively, whereas those in the I-Adeno group were 54.9% (95% CI, 42.0-67.9%) and 76.1% (95% CI, 63.7-88.4%), respectively. Multivariate analysis revealed that endocervical adenocarcinoma, usual type, or adenosquamous carcinoma, and tumor size >4 cm had worse RFS. ","subitem_description_type":"Abstract"},{"subitem_description":"Conclusion:\nThe I-SCC group had good prognosis without adjuvant therapy; therefore, adjuvant therapy may be omitted in these patients. In contrast, the I-Adeno group had poor prognosis without adjuvant therapy; therefore, adjuvant therapy should be considered in their treatment. ","subitem_description_type":"Abstract"}]},"item_4_description_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Journal Article","subitem_description_type":"Other"}]},"item_4_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Korean Society of Obstetrics and Gynecology"}]},"item_4_relation_10":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"33752280","subitem_relation_type_select":"PMID"}}]},"item_4_relation_11":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"10.5468/ogs.20243"}],"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.5468/ogs.20243","subitem_relation_type_select":"DOI"}}]},"item_4_relation_13":{"attribute_name":"PMCID","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"PMC7991004"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7991004/","subitem_relation_type_select":"URI"}}]},"item_4_rights_12":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© 2021 Korean Society of Obstetrics and Gynecology"}]},"item_4_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"22878572","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"YONEOKA, Yutaka"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"KOBAYASHI-KATO, Mayumi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"TANASE, Yasuhito"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"UNO, Masaya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"ISHIKAWA, Mitsuya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"MURAKAMI, Takashi"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"KATO, Tomoyasu"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-04-12"}],"displaytype":"detail","filename":"ogs.20243.pdf","filesize":[{"value":"190.5 kB"}],"format":"application/pdf","license_note":"Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ogs.20243","url":"https://shiga-med.repo.nii.ac.jp/record/3835/files/ogs.20243.pdf"},"version_id":"59c212d1-be17-49bf-a1ac-da61d1181ece"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Adenocarcinoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Carcinoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Recurrence","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Squamous cells","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Uterine cervical neoplasms","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"The baseline recurrence risk of patients with intermediate-risk cervical cancer.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The baseline recurrence risk of patients with intermediate-risk cervical cancer."}]},"item_type_id":"4","owner":"11","path":["216","281"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-04-12"},"publish_date":"2021-04-12","publish_status":"0","recid":"3835","relation_version_is_last":true,"title":["The baseline recurrence risk of patients with intermediate-risk cervical cancer."],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2023-06-19T11:37:12.039335+00:00"}